cytidine diphosphate choline has been researched along with Respiratory Distress Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, ES; Davis, IC; Rosas, LE; Yaxley, PE; Young, AA | 1 |
| Davis, IC; Doolittle, LM; El-Musa, H; Hickman-Davis, JM; Hite, RD; Joseph, LM; Novotny, MV; Rosas, LE | 1 |
| Biglino, A; Pescetti, G; Rigamonti, G | 1 |
1 trial(s) available for cytidine diphosphate choline and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Impact of cytidine diphosphocholine on oxygenation in client-owned dogs with aspiration pneumonia.
Topics: Animals; Cytidine; Cytidine Diphosphate Choline; Dog Diseases; Dogs; Hypoxia; Lung; Oxygen; Pneumonia, Aspiration; Respiratory Distress Syndrome; Saline Solution | 2022 |
2 other study(ies) available for cytidine diphosphate choline and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Postexposure Liponucleotide Prophylaxis and Treatment Attenuates Acute Respiratory Distress Syndrome in Influenza-infected Mice.
Topics: Alveolar Epithelial Cells; Animals; COVID-19; COVID-19 Drug Treatment; Cytidine Diphosphate Choline; Cytidine Diphosphate Diglycerides; Influenza A Virus, H1N1 Subtype; Mice; Orthomyxoviridae Infections; Respiratory Distress Syndrome; SARS-CoV-2 | 2021 |
[Physiopathology and clinical aspects of the alveolar surface active system (pulmonary surfactant)].
Topics: Adult; Chemical Phenomena; Chemistry; Cytidine Diphosphate Choline; Elasticity; Fatty Acids; Humans; Infant, Newborn; Kinetics; Lung; Phosphatidylcholines; Phospholipids; Pulmonary Alveoli; Pulmonary Surfactants; Respiratory Distress Syndrome; Respiratory Distress Syndrome, Newborn | 1977 |